Header Logo

Connection

Min Li to Humans

Back to Details
This is a "connection" page, showing publications Min Li has written about Humans.
Min Li
Connection Strength
1.348
Humans
  1. Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy. Cancer Res Commun. 2025 Aug 01; 5(8):1288-1297.
    View in: PubMed
    Score: 0.055
  2. Shared HLA-Bound Neoepitopes Are New Targets for Pancreatic Cancer Immunotherapy. Clin Cancer Res. 2025 May 15; 31(10):1821-1823.
    View in: PubMed
    Score: 0.054
  3. A zinc transporter drives glioblastoma progression via extracellular vesicles-reprogrammed microglial plasticity. Proc Natl Acad Sci U S A. 2025 May 06; 122(18):e2427073122.
    View in: PubMed
    Score: 0.054
  4. Combination therapies for cancer: challenges and opportunities. BMC Med. 2023 05 04; 21(1):171.
    View in: PubMed
    Score: 0.047
  5. Lysosomes Promote Cancer Metastasis via Exosome in PTEN-Deficient Tumors. Gastroenterology. 2023 03; 164(3):329-331.
    View in: PubMed
    Score: 0.046
  6. Patient-Derived Organoid Pharmacotyping Guides Precision Medicine for Pancreatic Cancer. Clin Cancer Res. 2022 08 02; 28(15):3176-3178.
    View in: PubMed
    Score: 0.044
  7. Acetyl-Coenzyme A Synthetase 2 Potentiates Macropinocytosis and Muscle Wasting Through Metabolic Reprogramming in Pancreatic Cancer. Gastroenterology. 2022 11; 163(5):1281-1293.e1.
    View in: PubMed
    Score: 0.044
  8. Targeted therapies for cancer. BMC Med. 2022 03 11; 20(1):90.
    View in: PubMed
    Score: 0.043
  9. EZH2, a prominent orchestrator of genetic and epigenetic regulation of solid tumor microenvironment and immunotherapy. Biochim Biophys Acta Rev Cancer. 2022 03; 1877(2):188700.
    View in: PubMed
    Score: 0.043
  10. Circular RNA ANAPC7 Inhibits Tumor Growth and Muscle Wasting via PHLPP2-AKT-TGF-ß Signaling Axis in Pancreatic Cancer. Gastroenterology. 2022 06; 162(7):2004-2017.e2.
    View in: PubMed
    Score: 0.043
  11. A Novel Translational Activation of HIF1a Promotes Pancreatic Cancer Growth Through Glycolytic Reprogramming. Gastroenterology. 2022 04; 162(4):1040-1042.
    View in: PubMed
    Score: 0.043
  12. Attenuating DNA damage response and immunosuppression radiosensitizes pancreatic cancer. EBioMedicine. 2022 Feb; 76:103822.
    View in: PubMed
    Score: 0.043
  13. Pancreatic Cancer: Targeted Therapy Holds the Promise. EBioMedicine. 2022 Jan; 75:103755.
    View in: PubMed
    Score: 0.043
  14. Interplay of Tumor Microenvironment Factors and Cancer Stem Cell Enrichment in Pancreatic Ductal Adenocarcinoma. Gastroenterology. 2021 12; 161(6):1800-1802.
    View in: PubMed
    Score: 0.042
  15. Evaluation of BRCA1 and BRCA2 as Indicators of Response to Immune Checkpoint Inhibitors. JAMA Netw Open. 2021 05 03; 4(5):e217728.
    View in: PubMed
    Score: 0.041
  16. An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer. EBioMedicine. 2021 Mar; 65:103271.
    View in: PubMed
    Score: 0.040
  17. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer. Gastroenterology. 2021 04; 160(5):1771-1783.e1.
    View in: PubMed
    Score: 0.040
  18. Genomic and single cell sequencing facilitate the dissection of heterogeneity of pancreatic tumors. BMC Med. 2020 07 08; 18(1):177.
    View in: PubMed
    Score: 0.039
  19. A subset of epithelial cells mimics regulatory T cells and contributes to immune evasion during development of pancreatic adenocarcinoma. BMC Med. 2020 06 29; 18(1):155.
    View in: PubMed
    Score: 0.038
  20. Socioeconomic gradient in health and the covid-19 outbreak. BMJ. 2020 04 01; 369:m1329.
    View in: PubMed
    Score: 0.038
  21. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin a3ß1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells. Gastroenterology. 2020 02; 158(3):679-692.e1.
    View in: PubMed
    Score: 0.037
  22. Pancreatic cancer: challenges and opportunities. BMC Med. 2018 11 22; 16(1):214.
    View in: PubMed
    Score: 0.034
  23. ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells. Gastroenterology. 2019 02; 156(3):722-734.e6.
    View in: PubMed
    Score: 0.034
  24. ZIP4 Promotes Pancreatic Cancer Progression by Repressing ZO-1 and Claudin-1 through a ZEB1-Dependent Transcriptional Mechanism. Clin Cancer Res. 2018 07 01; 24(13):3186-3196.
    View in: PubMed
    Score: 0.033
  25. Editorial - Special issue on Fighting Pancreatic Cancer. Cancer Lett. 2017 07 10; 398:22-23.
    View in: PubMed
    Score: 0.031
  26. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer. Cancer Lett. 2015 Jul 10; 363(1):1-6.
    View in: PubMed
    Score: 0.027
  27. Localized ablative immunotherapy enhances antitumor immunity by modulating the transcriptome of tumor-infiltrating Gamma delta T cells. Cancer Lett. 2024 Nov 01; 604:217267.
    View in: PubMed
    Score: 0.013
  28. Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges. Front Med. 2023 Dec; 17(6):1135-1169.
    View in: PubMed
    Score: 0.012
  29. Lysine methylation promotes NFAT5 activation and determines temozolomide efficacy in glioblastoma. Nat Commun. 2023 07 10; 14(1):4062.
    View in: PubMed
    Score: 0.012
  30. EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma. Oncogene. 2023 02; 42(6):461-470.
    View in: PubMed
    Score: 0.011
  31. Double burden of COVID-19 knowledge deficit: low health literacy and high information avoidance. BMC Res Notes. 2022 Feb 05; 15(1):27.
    View in: PubMed
    Score: 0.011
  32. Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Orthotopic Pancreatic Cancer. ACS Appl Mater Interfaces. 2021 Oct 27; 13(42):49614-49630.
    View in: PubMed
    Score: 0.011
  33. PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy. J Immunother Cancer. 2021 10; 9(10).
    View in: PubMed
    Score: 0.010
  34. MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Glycolysis in Pancreatic Cancer. Cancer Res. 2021 10 01; 81(19):4964-4980.
    View in: PubMed
    Score: 0.010
  35. Dexamethasone suppresses immune evasion by inducing GR/STAT3 mediated downregulation of PD-L1 and IDO1 pathways. Oncogene. 2021 Aug; 40(31):5002-5012.
    View in: PubMed
    Score: 0.010
  36. Acculturation and Health Literacy Among Chinese Speakers in the USA with Limited English Proficiency. J Racial Ethn Health Disparities. 2022 04; 9(2):489-497.
    View in: PubMed
    Score: 0.010
  37. A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening. Cancer Lett. 2021 03 01; 500:87-97.
    View in: PubMed
    Score: 0.010
  38. Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer. Mol Cancer. 2020 08 25; 19(1):130.
    View in: PubMed
    Score: 0.010
  39. Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical ß-catenin-dependent mechanism. Sci Rep. 2020 06 29; 10(1):10578.
    View in: PubMed
    Score: 0.010
  40. Molecular subtyping in pancreatic neuroendocrine neoplasms: New insights into clinical, pathological unmet needs and challenges. Biochim Biophys Acta Rev Cancer. 2020 08; 1874(1):188367.
    View in: PubMed
    Score: 0.009
  41. lncRNA-PLACT1 sustains activation of NF-?B pathway through a positive feedback loop with I?Ba/E2F1 axis in pancreatic cancer. Mol Cancer. 2020 02 21; 19(1):35.
    View in: PubMed
    Score: 0.009
  42. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis. Mol Cancer. 2019 11 07; 18(1):156.
    View in: PubMed
    Score: 0.009
  43. An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinoma. Proc Natl Acad Sci U S A. 2019 11 12; 116(46):23264-23273.
    View in: PubMed
    Score: 0.009
  44. Infantile Epithelioid Sarcoma with Genomic Segmental Amplification of BIRC3/YAP1 as Double Minutes Plus Trisomy 2: A Case Report. Fetal Pediatr Pathol. 2020 Feb; 39(1):51-61.
    View in: PubMed
    Score: 0.009
  45. A Novel Oxoglutarate Dehydrogenase-Like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and Metastasis. Clin Cancer Res. 2019 09 01; 25(17):5407-5421.
    View in: PubMed
    Score: 0.009
  46. A C-X-C Chemokine Receptor Type 2-Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis. Clin Cancer Res. 2019 06 01; 25(11):3317-3328.
    View in: PubMed
    Score: 0.009
  47. PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells. Cancer Res. 2019 01 01; 79(1):133-145.
    View in: PubMed
    Score: 0.009
  48. Local Phototherapy Synergizes with Immunoadjuvant for Treatment of Pancreatic Cancer through Induced Immunogenic Tumor Vaccine. Clin Cancer Res. 2018 11 01; 24(21):5335-5346.
    View in: PubMed
    Score: 0.008
  49. STAT3/HOTAIR Signaling Axis Regulates HNSCC Growth in an EZH2-dependent Manner. Clin Cancer Res. 2018 06 01; 24(11):2665-2677.
    View in: PubMed
    Score: 0.008
  50. Current Challenges and Opportunities for Chemoprevention of Pancreatic Cancer. Curr Med Chem. 2018; 25(22):2535-2544.
    View in: PubMed
    Score: 0.008
  51. Long Noncoding RNA NEAT1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/?-Catenin Pathway by Scaffolding EZH2. Clin Cancer Res. 2018 02 01; 24(3):684-695.
    View in: PubMed
    Score: 0.008
  52. Serum Monitoring and Phenotype Identification of Stage I Non-Small Cell Lung Cancer Patients. Cancer Invest. 2017 Oct 21; 35(9):573-585.
    View in: PubMed
    Score: 0.008
  53. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling. Cancer Lett. 2015 Apr 10; 359(2):314-24.
    View in: PubMed
    Score: 0.007
  54. Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner. Oncotarget. 2015 Jan 01; 6(1):537-46.
    View in: PubMed
    Score: 0.007
  55. Cord blood-derived cytokine-induced killer cellular therapy plus radiation therapy for esophageal cancer: a case report. Medicine (Baltimore). 2014 Dec; 93(28):e340.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.